Strategic Research Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

St test test test. This is a test. This sophomore a captioning test. California are looking at Carbon Pricing. Many as you heard over 30 have their own gas taxes. Some are going to tolling. So there are a lot of different ways we can raise revenues without focusing only on eds, which states are thinking about right now. I like to say there are no silver bullet, we need to learn from the states and see which work. We now have our chair and Ranking Member from our transportation infrastructure subcommittee. I want to salute them and their stats and leadership they are providing as we go through ...

Paolo Ghia, MD, PhD, discusses long-term efficacy data for fixed-duration ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia.

<p>Children born moderately (32-33 weeks) or late preterm (34-36 weeks) have higher long term risks of neurodevelopmental difficulties that can affect their behaviour and ability to learn, finds a study of over one million children published by<strong><em>&nbsp;The BMJ</em></strong>&nbsp;today.</p>

Paolo Ghia, MD, PhD, describes the various cohorts of the SEQUOIA study, expands on outcomes from a biomarker subgroup analysis with zanubrutinib vs bendamustine plus rituximab, and more.

Paolo Ghia, MD, PhD, full professor, discusses a biomarker subgroup analysis of the phase 3 SEQUOIA trial investigating zanubrutinib vs bendamustine plus rituximab in patients with treatment-naive chronic lymphocytic leukemia or small lymphocytic lymphoma without 17p deletions.